Patients With Severe Obesity Are Made Eligible for Complex Abdominal Wall Repair After Preoptimization With GLP-1 Agonists: Results of a Bicentric Pilot Study.

Fiche publication

Date publication

mars 2025

Journal

World journal of surgery

Auteurs

Membres identifiés du Cancéropôle Est :
Dr ROMAIN Benoit

Tous les auteurs :
Romain B, Pfirsch V, Manfredelli S, Leroi T, Salman F, Sami O, Westerfeld-Ruillier D, Ledoux S, Moszkowicz D

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/40088135

Résumé

Incisional hernia repairs (IHRs) are not recommended in patients with severe obesity (BMI ≥ 35 kg/m). Weight loss is challenging, but new medications, such as glucagon-like peptide-1 receptor agonists (GLP-1 agonists), have recently attracted increased attention for their potential weight loss advantages. The aim was to analyze the preliminary results about the safety and weight loss efficiency of the use of GLP-1 agonists in the context of prehabilitation prior to complex IHR.